Transcription of EASL-ALEH Clinical Practice Guidelines: Non …
{{id}} {{{paragraph}}}
EASL-ALEH Clinical Practice guidelines : Non- invasive testsfor evaluation of liver disease severity and prognosisEuropean Association for the Study of the Liver ,Asociaci n Latinoamericana para el Estudio del H gadoIntroductionLiver fibrosis is part of the structural and functional alterations inmost chronic liver diseases. It is one of the main prognostic fac-tors as the amount of fibrosis is correlated with the risk of devel-oping cirrhosis and liver-related complications in viral and non-viral chronic liver diseases [1,2]. Liver biopsy has traditionallybeen considered the reference method for evaluation of tissuedamage such as hepatic fibrosis in patients with chronic liver dis-ease. Pathologists have proposed robust scoring system for stag-ing liver fibrosis such as the semi-quantitative METAVIR score[3,4].
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis European Association for the Study of the Liver⇑
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}